<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">veterinary</journal-id><journal-title-group><journal-title xml:lang="en">Veterinary Science Today</journal-title><trans-title-group xml:lang="ru"><trans-title>Ветеринария сегодня</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2304-196X</issn><issn pub-type="epub">2658-6959</issn><publisher><publisher-name>"Veinard"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29326/2304-196X-2025-14-3-302-309</article-id><article-id custom-type="elpub" pub-id-type="custom">veterinary-946</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES | VETERINARY MICROBIOLOGY</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ | ВЕТЕРИНАРНАЯ МИКРОБИОЛОГИЯ</subject></subj-group></article-categories><title-group><article-title>Identification and some biological characteristics of Bacillus strains isolated from poultry large intestine</article-title><trans-title-group xml:lang="ru"><trans-title>Идентификация и некоторые биологические свойства изолятов бактерий рода Bacillus, выделенных из толстого отдела кишечника птицы</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4695-1077</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малик</surname><given-names>Н. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Malik</surname><given-names>N. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Малик Нина Ивановна - д-р биол. наук, профессор, главный научный сотрудник отдела научного планирования и НИР ФГБУ «ВГНКИ».</p><p>Звенигородское шоссе, 5, Москва, 123022</p></bio><bio xml:lang="en"><p>Nina I. Malik - Dr. Sci. (Biology), Professor, Chief Researcher, Department of Scientific Planning and Research, The Russian State Centеr for Quality and Standardization of Veterinary Drugs and Feed.</p><p>5 Zvenigorodskoe shosse, Moscow 123022</p></bio><email xlink:type="simple">nimalik@vgnki.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-8358-0618</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чупахина</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chupahina</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чупахина Наталия Александровна - канд. биол. наук, ведущий научный сотрудник отдела бактериологии ФГБУ «ВГНКИ».</p><p>Звенигородское шоссе, 5, Москва, 123022</p></bio><bio xml:lang="en"><p>Nataliya A. Chupahina - Cand. Sci. (Biology), Leading Researcher, Department of Bacteriology, The Russian State Centеr for Quality and Standardization of Veterinary Drugs and Feed.</p><p>5 Zvenigorodskoe shosse, Moscow 123022</p></bio><email xlink:type="simple">n.chupahina@vgnki.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-3388-2990</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Русанов</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Rusanov</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Русанов Иван Анатольевич - старший научный сотрудник научно-технологической лаборатории ФГБУ «ВГНКИ».</p><p>Звенигородское шоссе, 5, Москва, 123022</p></bio><bio xml:lang="en"><p>Ivan A. Rusanov - Senior Researcher, Scientific and Technological Laboratory, The Russian State Centеr for Quality and Standardization of Veterinary Drugs and Feed.</p><p>5 Zvenigorodskoe shosse, Moscow 123022</p></bio><email xlink:type="simple">rusanov@vgnki.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7836-3010</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малик</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Malik</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Малик Евгений Васильевич - канд. вет. наук, ведущий научный сотрудник отдела научного планирования и НИР ФГБУ «ВГНКИ».</p><p>Звенигородское шоссе, 5, Москва, 123022</p></bio><bio xml:lang="en"><p>Evgeniy V. Malik - Cand. Sci. (Veterinary Medicine), Leading Researcher, Department of Scientific Planning and Research, The Russian State Centеr for Quality and Standardization of Veterinary Drugs and Feed.</p><p>5 Zvenigorodskoe shosse, Moscow 123022</p></bio><email xlink:type="simple">evmalik@vgnki.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3149-8625</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маленкова</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Malenkova</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Маленкова Лия Андреевна - старший научный сотрудник отдела бактериологии ФГБУ «ВГНКИ».</p><p>Звенигородское шоссе, 5, Москва, 123022</p></bio><bio xml:lang="en"><p>Liya A. Malenkova - Senior Researcher, Department of Bacteriology, The Russian State Centеr for Quality and Standardization of Veterinary Drugs and Feed.</p><p>5 Zvenigorodskoe shosse, Moscow 123022</p></bio><email xlink:type="simple">l.malenkova@vgnki.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-3519-7838</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Самохвалова</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Samokhvalova</surname><given-names>N. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Самохвалова Надежда Сергеевна - научный сотрудник отдела бактериологии ФГБУ «ВГНКИ».</p><p>Звенигородское шоссе, 5, Москва, 123022</p></bio><bio xml:lang="en"><p>Nadezhda S. Samokhvalova - Researcher, Department of Bacteriology, The Russian State Centеr for Quality and Standardization of Veterinary Drugs and Feed.</p><p>5 Zvenigorodskoe shosse, Moscow 123022</p></bio><email xlink:type="simple">n.samokhvalova@vgnki.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-1870-4292</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сурогин</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Surogin</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сурогин Михаил Витальевич - канд. вет. наук, заведующий отделом бактериологии, ФГБУ «ВГНКИ».</p><p>Звенигородское шоссе, 5, Москва, 123022</p></bio><bio xml:lang="en"><p>Mikhail V. Surogin - Cand. Sci. (Veterinary Medicine), Head of Department of Bacteriology, The Russian State Centеr for Quality and Standardization of Veterinary Drugs and Feed.</p><p>5 Zvenigorodskoe shosse, Moscow 123022</p></bio><email xlink:type="simple">surogin@vgnki.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Всероссийский государственный Центр качества и стандартизации лекарственных средств для животных и кормов» (ФГБУ «ВГНКИ»)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>The Russian State Centеr for Quality and Standardization of Veterinary Drugs and Feed</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>17</day><month>09</month><year>2025</year></pub-date><volume>14</volume><issue>3</issue><fpage>302</fpage><lpage>309</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Malik N.I., Chupahina N.A., Rusanov I.A., Malik E.V., Malenkova L.A., Samokhvalova N.S., Surogin M.V., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Малик Н.И., Чупахина Н.А., Русанов И.А., Малик Е.В., Маленкова Л.А., Самохвалова Н.С., Сурогин М.В.</copyright-holder><copyright-holder xml:lang="en">Malik N.I., Chupahina N.A., Rusanov I.A., Malik E.V., Malenkova L.A., Samokhvalova N.S., Surogin M.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://veterinary.arriah.ru/jour/article/view/946">https://veterinary.arriah.ru/jour/article/view/946</self-uri><abstract><sec><title>Introduction</title><p>Introduction. Censuses of phylogenetic diversity of bacteria colonizing the intestinal tract of clinically healthy poultry conducted over the past decade indicate that up to 60% of genera present in the gut microbiome contain spore-forming bacteria, accounting for 30% of total gut microbiota. Benefits associated with using probiotics containing Bacillus spore-forming bacteria have been documented. Analysis of the prevalence of hemolytic and potential biofilm-forming activity, as well as antibiotic resistance in poultry gut spore-forming microbiota is essential for understanding the true role of aerobic spore-formers of the Bacillus genus in avian gut microbiome ecology.</p></sec><sec><title>Objective</title><p>Objective. Identification and investigation of biological characteristics (hemolytic activity, potential biofilm-forming capacity and antibiotic resistance) of Bacillus bacterial isolates obtained from the large intestine of poultry.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Spore-forming bacteria were isolated from cecal content through sample heat treatment. Phenotypic identification was performed using API 50CHB biochemical test panels (bioMérieux, France). Hemolytic properties were assessed using Columbia agar (HiMedia Laboratories Pvt Ltd., India) supplemented with 5% sterile defibrinated sheep blood; catalase activity was assessed using 10% hydrogen peroxide according to General Pharmacopoeia Monograph GPM.1.7.2.0012.15; antibiotic sensitivity was assessed with disk diffusion test involving standard antibiotic-impregnated disks (5–30 μg/disk). Biofilm-producing, spore-forming bacteria were tested qualitatively using brain-heart infusion agar (BHI; HiMedia Laboratories Pvt Ltd., India) supplemented with Congo red and 5% sucrose.</p></sec><sec><title>Results</title><p>Results. It was established that the cecal aerobic spore-forming microbiota in poultry comprised B. licheniformis, B. subtilis/amyloliquefaciens, B. mycoides, B. megaterium and B. cereus. All tested isolates were catalase-positive and lacked α-hemolytic activity. Some isolates demonstrated β-hemolytic activity. The overwhelming majority exhibited biofilm-forming phenotypes and showed susceptibility to tested antibiotics.</p></sec><sec><title>Conclusion</title><p>Conclusion. Vegetative forms of Bacillus spore-forming bacteria may potentially persist in or temporarily associate with the complex gut ecosystem. Hemolytically active intestinal isolates cannot be considered safe until the effects of this virulence factor on animals are clarified. These findings provide a basis for selecting candidate Bacillus strains for probiotic development.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Введение</title><p>Введение. Проведенная за последнее десятилетие перепись филогенетического разнообразия бактерий, колонизирующих кишечный тракт клинически здоровой птицы, показывает, что до 60% родóв, присутствующих в микробиоме кишечника, содержат спорообразующие бактерии, и эти роды составляют 30% от общей кишечной микробиоты. Были зарегистрированы преимущества, связанные с использованием пробиотиков, содержащих спорообразующие бактерии рода Bacillus. Анализ широты распространения гемолитической и потенциальной биопленкообразующей активности, а также антибиотикорезистентности у кишечной популяции споробиоты птицы необходим для понимания истинной роли аэробных спорообразователей рода Bacillus в экологии кишечного микробиома птицы.</p></sec><sec><title>Цель работы</title><p>Цель работы. Идентификация и исследование биологических характеристик (гемолитическая активность, потенциальная способность к биопленкообразованию и антибиотикорезистентность) изолятов бактерий рода Bacillus, выделенных из толстого отдела кишечника птицы.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Выделение спорообразующих бактерий из содержимого слепых отростков толстого кишечника птицы проводили путем прогревания образцов. Фенотипическую идентификацию изолятов осуществляли с использованием биохимических тест-панелей API 50CHB (bioMérieux, Франция). Гемолитические свойства определяли на колумбийском агаре (HiMedia Laboratories Pvt Ltd., Индия) с добавлением 5% стерильной дефибринированной крови барана; каталазную активность – в тесте с 10%-й перекисью водорода по ОФС.1.7.2.0012.15; чувствительность к антибиотикам – диско-диффузионным методомсостандартными дисками, импрегнированными антибиотиками вконцентрациях от5до 30 μg/disk. Скрининг спорообразующих бактерий – продуцентов биопленки проводили качественным методом на сердечно-мозговом агаре (HiMedia Laboratories Pvt Ltd., Индия) с добавлением индикатора конго красного и 5% сахарозы.</p></sec><sec><title>Результаты</title><p>Результаты. Установлено, что кишечная популяция аэробной споробиоты слепых отростков толстого кишечника птицы представлена видами B. licheniformis, B. subtilis/amyloliquefaciens, B. mycoides, B. megaterium и B. сereus. Все изученные изоляты были каталазоположительными, не обладали α-гемолитической активностью. У части изолятов отмечена β-гемолитическая активность. Подавляющее большинство изолятов относились к биопленкообразующим фенотипам и проявляли чувствительность к тестируемым антибиотикам.</p></sec><sec><title>Заключение</title><p>Заключение. Вегетативные формы спорообразующих бактерий рода Bacillus потенциально могут сохраняться в сложной экосистеме кишечника или временно ассоциироваться с ней. Гемолитически активные кишечные изоляты спорообразующих бактерий не могут считаться безопасными до выяснения действия этого фактора вирулентности на организм животных. Результаты исследований могут быть использованы при отборе кандидатных штаммов бактерий рода Bacillus, выбранных в качестве пробиотиков.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>споробиота</kwd><kwd>гемолиз</kwd><kwd>биопленка</kwd><kwd>антибиотикорезистентность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>sporobiota</kwd><kwd>hemolysis</kwd><kwd>biofilm</kwd><kwd>antibiotic resistance</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование финансировалось Федеральной службой по ветеринарному и фитосанитарному надзору, научно-исследовательский проект АААА-А20-120012790050-7 по теме «Диагностика состояния нормальной микробиоты желудочно-кишечного тракта сельскохозяйственной птицы под воздействием антимикробных и пробиотических препаратов для разработки и осуществления мер по ее сохранению или восстановлению».</funding-statement><funding-statement xml:lang="en">The study was funded by the Federal Service for Veterinary and Phytosanitary Surveillance (Rosselkhoznadzor) within Research Project No. AAAA-A20-120012790050-7“Diagnostic monitoring of poultry gut microbiota responses to antimicrobial and probiotic agents for developing and implementing measures to ensure microbiome preservation and restoration”.</funding-statement></funding-group></article-meta></front><body><sec><title>INTRODUCTION</title><p>The gut microbiota is crucial for maintaining host health by supplying essential nutrients, regulating energy balance, modulating immune responses and protecting against pathogens. Consequently, restoring and maintaining its stability with beneficial bacteria – rather than antibiotics – has been proposed as a strategy to prevent adverse effects on gut health [<xref ref-type="bibr" rid="cit1">1</xref>].</p><p>A census of the phylogenetic diversity of bacteria identified in the intestinal tract of healthy poultry conducted over the past decade shows that up to 60% of the genera present in the gut microbiome contain spore-forming bacteria, and these genera account for 30% of the total gut microbiota [<xref ref-type="bibr" rid="cit2">2</xref>][<xref ref-type="bibr" rid="cit3">3</xref>].</p><p>In microbiome research, spore-forming bacteria are considered a distinct functional group within the broader microbiota. The term “sporobiota” has been proposed to describe the total collection of these bacteria in a given microbial community [<xref ref-type="bibr" rid="cit4">4</xref>].</p><p>Endospores are formed by members of Firmicutes, a large, diverse and morphologically complex bacterial phylum [<xref ref-type="bibr" rid="cit5">5</xref>]. Within it, species of the genus Bacillus (family Bacillaceae) have attracted the most scientific attention due to their significant role in modulating the intestinal microbiota [<xref ref-type="bibr" rid="cit6">6</xref>].</p><p>While spore-forming bacteria of the genus Bacillus are primarily associated with the soil microbiome [<xref ref-type="bibr" rid="cit7">7</xref>], their presence in the intestine is attributed to the consumption of feed and water. It has been conventionally assumed that Bacillus species enter the intestine exclusively in their spore form [<xref ref-type="bibr" rid="cit8">8</xref>]. However, accumulating evidence suggests that some Bacillus species exhibit a bimodal life cycle, capable of both growth and sporulation not only in the environment but also within the gastrointestinal tract [<xref ref-type="bibr" rid="cit9">9</xref>][<xref ref-type="bibr" rid="cit10">10</xref>].</p><p>Spore-forming bacteria of the genus Bacillus are widely used in animal feed to promote animal growth and inhibit pathogens [<xref ref-type="bibr" rid="cit11">11</xref>][<xref ref-type="bibr" rid="cit12">12</xref>]. The probiotic mechanisms of these microorganisms involve synthesizing antimicrobial compounds and lactic acid [<xref ref-type="bibr" rid="cit13">13</xref>], enhancing non-specific immunity [<xref ref-type="bibr" rid="cit14">14</xref>], and producing enzymes such as amylase, lipase, protease, pectinase and cellulose [<xref ref-type="bibr" rid="cit15">15</xref>]. Specifically, Bacillus subtilis stimulates growth of beneficial gut microbiota, increases intestinal microbiome diversity [<xref ref-type="bibr" rid="cit16">16</xref>], modulates regulatory systems for intestinal epithelium renewal and immune cell activity [<xref ref-type="bibr" rid="cit17">17</xref>], and mitigates the adverse effects of various factors, particularly antibiotic therapy [<xref ref-type="bibr" rid="cit18">18</xref>][<xref ref-type="bibr" rid="cit19">19</xref>].</p><p>It has also been shown that B. subtilis plays an important role in stimulating the development of gut-associated lymphoid tissue and that sporulation of live bacilli is considered critical for this process [<xref ref-type="bibr" rid="cit20">20</xref>][<xref ref-type="bibr" rid="cit21">21</xref>].</p><p>Survival and colonization within the digestive tract are essential for the microbiota to exert its physiological functions [<xref ref-type="bibr" rid="cit22">22</xref>]. For spore-forming bacteria, a key prerequisite for intestinal colonization is the adhesion of spores to the intestinal mucosa and subsequent biofilm formation, a process that enables the transition of planktonic cells to attached forms [<xref ref-type="bibr" rid="cit21">21</xref>][<xref ref-type="bibr" rid="cit23">23</xref>].</p><p>The term “biofilm” is used to describe a structured community of bacterial cells embedded in a self-produced polymeric extracellular matrix and adhered to an inert or living surface [<xref ref-type="bibr" rid="cit24">24</xref>]. This polymeric extracellular matrix is a complex system composed of exopolysaccharides, the TasA protein, lipids, nucleic acids and various heteropolymers, all of which are secreted by microorganisms into the extracellular environment [<xref ref-type="bibr" rid="cit25">25</xref>]. Studies have shown that the TasA protein and exopolysaccharides are key components of the Bacillus biofilm matrix. TasA is an amyloid protein that has been implicated in the formation of the biofilm matrix by various microorganisms, including spore-forming bacteria [<xref ref-type="bibr" rid="cit26">26</xref>][<xref ref-type="bibr" rid="cit27">27</xref>][<xref ref-type="bibr" rid="cit28">28</xref>][<xref ref-type="bibr" rid="cit29">29</xref>].</p><p>Bacterial biofilms can protect bacteria from environmental stressors, host immune responses and antimicrobial agents, including antibiotics [<xref ref-type="bibr" rid="cit30">30</xref>].</p><p>The use of Congo red dye to assess bacterial amyloid synthesis, and thus identify mucus or biofilm-forming organisms like Staphylococcus sp., was first proposed by D. J. Freeman et al. [<xref ref-type="bibr" rid="cit31">31</xref>]. This method distinguishes biofilm-forming Staphylococcus colonies from non-forming ones based on their morphology and color on Congo red agar. Subsequent studies confirmed the utility of this assay for detecting potential biofilm formation in a broad spectrum of gram-positive and gram-negative microorganisms, including spore-forming bacteria of the genus Bacillus [<xref ref-type="bibr" rid="cit32">32</xref>][<xref ref-type="bibr" rid="cit33">33</xref>][<xref ref-type="bibr" rid="cit34">34</xref>].</p><p>Recent data indicates that Bacillus sporulation is more active within biofilms than in planktonic cultures [<xref ref-type="bibr" rid="cit35">35</xref>].</p><p>The growing threat of antibiotic-resistant pathobiont spread has brought to the forefront research focused on assessing the antibiotic resistance of the commensal gut microbiota as potential donors of resistance determinants.</p><p>In light of this problem, it has been suggested that spore-forming bacteria may play a significant role in the dissemination and accumulation of antibiotic resistance genes due to their ability to withstand antibiotic treatment [<xref ref-type="bibr" rid="cit36">36</xref>][<xref ref-type="bibr" rid="cit37">37</xref>]. However, the extent of antibiotic resistance and the biofilm-forming capacity among members of the intestinal sporobiota remain largely unknown.</p><p>Previous studies on the spread of antibiotic resistance and the biofilm-forming ability of Bacillus bacteria were focused on a limited number of species and did not include isolates derived from poultry gut microbiota [<xref ref-type="bibr" rid="cit38">38</xref>][<xref ref-type="bibr" rid="cit39">39</xref>][<xref ref-type="bibr" rid="cit40">40</xref>][<xref ref-type="bibr" rid="cit41">41</xref>].</p><p>The prevalence of hemolytic activity within the intestinal population of aerobic Bacillus bacteria remains insufficiently studied. Furthermore, the role of their hemolysins in maintaining intestinal mucosal integrity is unclear, and it has not been established that hemolysin production is harmless to the host. Non-hemolytic (γ-hemolytic) strains are generally considered safe for their hosts, while strains exhibiting hemolytic activity are deemed pathogenic [<xref ref-type="bibr" rid="cit42">42</xref>][<xref ref-type="bibr" rid="cit43">43</xref>].</p><p>Given the modern understanding of the gut microbiota’s role in maintaining gut colonization resistance, this knowledge gap leads to a lack of understanding regarding the true role of aerobic Bacillus spore-formers in the poultry gut microbiome and the specificity required for their selection and application as probiotics [<xref ref-type="bibr" rid="cit44">44</xref>][<xref ref-type="bibr" rid="cit45">45</xref>].</p><p>The relevance of this work is that the safety assessment of aerobic spore-forming Bacillus bacteria, which are widely used in the production of probiotic feed additives, is associated not only with species identification but also with the individual characteristics of the strains.</p><p>The novelty of the obtained data lies in the study of specific biological properties of isolates from the ceca of commercial poultry, thereby evaluating the prospects of using Bacillus bacteria for developing probiotic feed supplements.</p><p>The aim of this work is to investigate the biological properties of Bacillus isolates (hemolytic activity, potential for biofilm formation, and antibiotic resistance) obtained from the large intestine of poultry, with the goal of selecting promising strains for use in the biotechnology of probiotic production.</p></sec><sec><title>MATERIALS AND METHODS</title><p>Spore-forming bacteria used in this study were isolated from samples of the cecal content of clinically healthy poultry obtained from farms in the Moscow Oblast that are free from infectious diseases. Birds were euthanized in the animal facility using CO₂ and subjected to necropsy according to a standard protocol. All animal procedures complied with the ethical standards set by European Convention ETS No. 123.</p><p>The ceca were isolated by applying ligatures at the junction with the rectum, excised, placed in separate containers and transported to the laboratory under a cold chain (2–8 °C). Within maximum 30 minutes of obtaining the isolated ceca, the contents of each were extruded into sterile disposable dishes and labeled. The resulting aliquots of each chyme sample were diluted 1:100 with buffered peptone water and resuspended by vigorous mixing to obtain a homogeneous suspension.</p><p>To isolate spore-forming bacteria, the aliquots were heated in a water bath at 65 °C for 45 minutes [<xref ref-type="bibr" rid="cit46">46</xref>].</p><p>To obtain isolated colonies, the heated aliquots were streaked onto Tryptic Soy Agar (SCD agar; HiMedia Laboratories Pvt Ltd., India). Cultivation was carried out under aerobic conditions at (37 ± 1) °C. The cultures were examined after 18, 24, and 36 hours of incubation.</p><p>Colonies exhibiting morphological characteristics of the Bacillus genus were selected and purified by repeated streaking on SCD agar. After 18 and 24 hours of cultivation, following visual assessment of growth and microscopy of gram-stained smears, isolates of spore-forming bacteria were subcultured into Tryptic Soy Broth (TSB; SCD broth; HiMedia Laboratories Pvt Ltd., India), and broth cultures of vegetative cells were used for further work.</p><p>Phenotypic characterization. A phenotypic characterization of the spore-forming bacterial isolates was performed based on morphological properties, Gram staining,hemolytic activity, catalase activity, biofilm-forming capacity and antibiotic susceptibility. All tests were performed in duplicate.</p><p>Isolate identification. Phenotypic identification of the spore-forming bacterial isolates was conducted using commercial disposable biochemical diagnostic test panels API 50CHB (bioMérieux, France). This test classifies bacterial strains based on their ability to ferment 49 different carbohydrates. Results were analyzed using the APIWEB™ software (bioMérieux, France).</p><p>Hemolytic activity test. The hemolytic properties of the spore-forming bacterial isolates were determined using Columbia agar (HiMedia Laboratories Pvt Ltd., India) supplemented with 5% sterile defibrinated sheep blood. Twenty-four-hour cultures of the isolates were stab-inoculated onto the agar surface. The reaction was recorded 24 hours after incubation at (37 ± 1) °C. An isolate was considered α-hemolytic if colonies caused a green or brown discoloration of the surrounding medium, β-hemolytic if true lysis of erythrocytes resulted in a clear, transparent zone surrounding the colonies, and γ-hemolytic (non-hemolytic) if no reaction was observed in the surrounding medium [<xref ref-type="bibr" rid="cit47">47</xref>].</p><p>Catalase test. The catalase activity of bacterial isolates was determined using a 10% hydrogen peroxide solution [<xref ref-type="bibr" rid="cit48">48</xref>]. The liberation of oxygen, evident by the formation of gas bubbles, indicated catalase production.</p><p>Antibiotic susceptibility test. The antibiotic susceptibility of Bacillus sp. isolates was tested using the disk diffusion method [<xref ref-type="bibr" rid="cit49">49</xref>]. Standard antibiotic-impregnated discs (HiMedia Laboratories Pvt Ltd., India) with the following concentrations (5 to 30 μg/disk) were used: ciprofloxacin (Cip 5), rifampicin (Rif 5), enrofloxacin (Ex5), doxycycline (Do10), gentamicin (Gen10), neomycin (N30), cefazolin (Cz30), norfloxacin (Nx10), benzylpenicillin (P100), pefloxacin (Pf5), kanamycin (K30), lincomycin (L15), azithromycin (AZM15), nalidixic acid (NA30), chloramphenicol (C30), oxytetracycline (O30), imipenem (Ipm10), oleandomycin (Ol15), clindamycin (Cd2), clarithromycin (Clr15), oxacillin (Ox1), ampicillin (Amp25).</p><p>Eighteen-hour agar cultures of spore-forming bacteria were adjusted to a 0.5 McFarland standard; 250 μL of the culture was swabbed onto the surface of SCD agar plates, and antibiotic discs were dispensed (8 per plate) using a dispenser (HiMedia Laboratories Pvt Ltd., India). Plates were then incubated at (37 ± 1) °C for 20–24 hours.</p><p>Strains were classified as resistant (R) if the inhibition zone diameters for the antibiotics listed in EFSA (European Food Safety Authority) documents exceeded the threshold level for Bacillus strains [<xref ref-type="bibr" rid="cit50">50</xref>]. For antibiotics lacking reliable interpretive criteria, Bacillus strains exhibiting inhibition zones of less than 12 mm around the antibiotic disc were considered resistant.</p><p>Determination of biofilm producers. Screening of spore-forming bacteria as potential biofilm producers was performed using a qualitative method by detecting extracellular amyloid proteins on Brain Heart Infusion Agar (BHI agar; HiMedia Laboratories Pvt Ltd., India) supplemented with Congo red indicator and 5% sucrose [<xref ref-type="bibr" rid="cit31">31</xref>].</p><p>A 24-hour broth culture of the test isolate was stabinoculated onto Congo red BHI agar and incubated for 48 hours at (37 ± 1) °C. The color and morphology of the resulting colonies were assessed visually.</p><p>The interaction of Congo red with amyloid proteins of the biofilm produces a compound that gives colonies a dark red or dark brown color with a black base. Weak biofilm producers typically remain pink, though some darkening in the center may be observed. Isolates incapable of forming biofilms produce white or very light pink colonies [<xref ref-type="bibr" rid="cit51">51</xref>].</p></sec><sec><title>RESULTS AND DISCUSSION</title><p>During the study, a total of 68 strains of aerobic spore-forming bacteria of the genus Bacillus were isolated and identified to the species level.</p><p>Phenotypic data confirmed that the isolates obtained from the contents of the ceca of the large intestine of clinically healthy birds belonged to spore-forming bacteria.</p><p>The identified isolates of spore-forming bacteria were represented by 5 species: Bacillus licheniformis, Bacillus subtilis/amyloliquefaciens, Bacillus megaterium, Bacillus cereus and Bacillus mucoides. A number of isolates could not be identified using the standardized API 50CHB system.</p><p>Microscopic examination of the isolated cells revealed a diverse collection of rod-shaped bacteria producing endospores of various sizes and shapes.</p><p>The colonies of spore-forming bacteria exhibited significant polymorphism. B. licheniformis isolates, after 18–24 hours of growth on SCD agar, formed raised, medium-sized colonies colored white or beige, with a flower-like shape.</p><p>When cultured on SCD agar, B. subtilis/amyloliquefaciens isolates grew into large white, medium-sized colonies with a lighter central point, or rough undulating colonies of a white-cream color with a dry, finely wrinkled structure, slightly raised above the agar surface.</p><p>Bacillus megaterium isolates on SCD agar formed sharply defined colonies of a dirty white color.</p><p>Morphologically, the colonies of B. mucoides and B. cereus isolates were identical and appeared as rough, spreading, rhizoid, greyish-white colonies with undulating edges, or as wrinkled, milky-colored colonies with wavy edges.</p><p>The isolated spore-forming bacteria were assessed for their safety based on hemolytic activity (Table 1).</p><table-wrap id="table-1"><caption><p>Table 1</p><p>Hemolytic activity and biofilm-forming capacity of spore-forming bacterial isolates from poultry cecal appendages</p></caption><table><tbody><tr><td>Isolate species identification using the standardized API 50CHB system</td><td>Total number of isolates</td><td>Number of hemolytically active isolates</td><td>Number of isolates – potential biofilm producers</td></tr><tr><td>Type of hemolysis</td></tr><tr><td>α</td><td>β</td><td>γ</td></tr><tr><td>B. licheniformis</td><td>26</td><td>0</td><td>4</td><td>6</td><td>23</td></tr><tr><td>B. subtilis/amyloliquefaciens</td><td>16</td><td>0</td><td>3</td><td>1</td><td>16</td></tr><tr><td>B. megaterium</td><td>3</td><td>0</td><td>2</td><td>1</td><td>2</td></tr><tr><td>B. mycoides</td><td>5</td><td>0</td><td>0</td><td>0</td><td>5</td></tr><tr><td>B. cereus</td><td>7</td><td>0</td><td>5</td><td>1</td><td>5</td></tr><tr><td>Unidentified species</td><td>11</td><td>0</td><td>5</td><td>4</td><td>not tested</td></tr><tr><td>Total</td><td>68</td><td>0</td><td>19</td><td>13</td><td>51</td></tr></tbody></table></table-wrap><p>All isolates of spore-forming bacteria obtained from the chyme samples of birds’ ceca lacked α-hemolytic activity. Growth on blood agar revealed a wide zone of hemolysis, characteristic of β-hemolytic bacteria, in 14 out of the 57 studied isolates of the species B. licheniformis, B. subtilis/amyloliquefaciens, B. megaterium, and B. cereus (Fig. 1). It was found that 9 isolates of spore-forming bacteria exhibited γ-hemolytic activity.</p><fig id="fig-1"><caption><p>Fig. 1. Hemolytic activity of Bacillus isolates cultured on sheep blood-supplemented SCD agar at (37 ± 1) °C for 24 hours</p></caption><graphic xlink:href="veterinary-14-3-g001.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/veterinary/2015/3/DLZ7A0uXaHJzFBW7o1fEJ1F3DiG7yHMVB5Uw8xeP.jpeg</uri></graphic></fig><p>The majority of the studied isolates of spore-forming microorganisms grown on Congo red BHI agar were classified as potential biofilm producers based on their dark red colonies with a black base, with the exception of 3 isolates of B. licheniformis, 1 isolate of B. megaterium, and 2 isolates of B. cereus, which formed light pink colonies (Fig. 2).</p><fig id="fig-2"><caption><p>Fig. 2. Bacillus isolates cultured on Congo red-supplemented BHI agar at (37 ± 1) °C for 24 hours</p></caption><graphic xlink:href="veterinary-14-3-g002.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/veterinary/2015/3/XRQSCoJTGhcRiXtNsKlq1Xfzb8eNSpnMM8Apvrab.jpeg</uri></graphic></fig><p>Antibiotic susceptibility tests showed that the majority of the studied isolates of spore-forming bacteria were sensitive to all 22 antibiotics tested (Table 2).</p><table-wrap id="table-2"><caption><p>Table 2</p><p>Antibiotic sensitivity profiles of 57 spore-forming isolates determined using disk diffusion method</p></caption><table><tbody><tr><td>№
п/п</td><td>Antibiotic disc type</td><td>Number of antibiotic-sensitive isolates</td></tr><tr><td>B. licheniformis 
(n = 26)</td><td>B. subtilis/ amyloliquefaciens 
(n = 16)</td><td>B. megaterium 
(n = 3)</td><td>B. mycoides
(n = 5)</td><td>B. cereus
(n = 7)</td></tr><tr><td>1</td><td>Ciprofloxacin (5 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>2</td><td>Rifampicin (5 μg/disk)</td><td>2</td><td>1</td><td>1</td><td>+</td><td>+</td></tr><tr><td>3</td><td>Enrofloxacin (5 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>4</td><td>Doxycycline (10 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>5</td><td>Gentamicin (10 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>6</td><td>Neomycin (30 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>7</td><td>Cefazolin (30 μg/disk)</td><td>3</td><td>+</td><td>1</td><td>+</td><td>3</td></tr><tr><td>8</td><td>Norfloxacin (10 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>9</td><td>Benzylpenicillin (100 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>10</td><td>Pefloxacin (5 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>11</td><td>Kanamycin (30 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>1</td><td>+</td></tr><tr><td>12</td><td>Lincomycin (15 μg/disk)</td><td>8</td><td>3</td><td>1</td><td>+</td><td>+</td></tr><tr><td>13</td><td>Azithromycin (15 μg/disk)</td><td>+</td><td>2</td><td>+</td><td>+</td><td>+</td></tr><tr><td>14</td><td>Nalidixic acid (30 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>15</td><td>Chloramphenicol (30 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>16</td><td>Oxytetracycline (30 μg/disk)</td><td>2</td><td>2</td><td>+</td><td>1</td><td>1</td></tr><tr><td>17</td><td>Imipenem (10 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>18</td><td>Oleandomycin (15 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>19</td><td>Ampicillin (25 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>20</td><td>Clindamycin (2 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>21</td><td>Clarithromycin (15 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>22</td><td>Oxacillin (1 μg/disk)</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr></tbody></table></table-wrap><p>Only 4 isolates of spore-forming bacteria were resistant to rifampicin, 7 – to cefazolin, 12 – to lincomycin, and 6 – to oxytetracycline. Some isolates were resistant to 2 antibiotics, but the majority of isolates exhibited resistance to maximum one antibiotic.</p></sec><sec><title>CONCLUSION</title><p>Based on the test results, the identified species of spore-forming bacteria of the genus Bacillus isolated from the ceca of commercial poultry included: B. licheniformis, B. subtilis/amyloliquefaciens, B. mycoides, B. megaterium and B. cereus; a number of isolates could not be identified.</p><p>All studied isolates were catalase-positive and lacked α-hemolytic activity. Some isolates exhibited β-hemolytic activity, which precludes their classification as non-pathogenic.</p><p>The potential ability of the isolated strains to form biofilms, which indirectly characterizes their capacity to survive in the intestine, was additionally investigated. The vast majority of isolates were classified as potential biofilm-forming phenotypes and demonstrated susceptibility to all 22 tested antibiotics.</p><p>Hemolytically active intestinal isolates of spore-forming bacteria cannot be considered safe until the effect of this virulence factor on the animal organism is elucidated.</p><p>The research results can be used for the selection of candidate strains of bacteria of the genus Bacillus chosen as probiotics.</p><p>Contribution of the authors: Malik N. I. – scientific supervision, research implementation, methodology, formal analysis, manuscript writing; Chupahina N. A. and Rusanov I. A. – investigation, formal analysis and data processing, table preparation, digital image preparation; Malik E. V. – formal analysis, data processing, article manuscript preparation; Malenkova L. A. and Samokhvalova N. S. – literature review and analysis; Surogin M. V. – text editing.</p><p>Вклад авторов: Малик Н. И. – научное руководство, проведение исследований, методология, формальный анализ, написание текста статьи; Чупахина Н. А. и Русанов И. А. – исследование, формальный анализ и обработка данных, составление таблиц, подготовка цифровых снимков; Малик Е. В. – формальный анализ, обработка данных, подготовка текста статьи; Маленкова Л. А. и Самохвалова Н. С. – подбор и анализ литературных источников по теме; Сурогин М. В. – редактирование текста.</p></sec></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Von Martels J. Z., Sadabad M. S., Bourgonje A. R., Blokzijl T., Dijkstra G., Faber K. N., Harmsen H. J. M. The role of gut microbiota in health and disease: in vitro modeling of host-microbe interactions at the aerobe-anaerobe interphase of the human gut. Anaerobe. 2017; 44: 3–12. https://doi.org/10.1016/j.anaerobe.2017.01.001</mixed-citation><mixed-citation xml:lang="en">Von Martels J. Z., Sadabad M. S., Bourgonje A. R., Blokzijl T., Dijkstra G., Faber K. N., Harmsen H. J. M. The role of gut microbiota in health and disease: in vitro modeling of host-microbe interactions at the aerobe-anaerobe interphase of the human gut. Anaerobe. 2017; 44: 3–12. https://doi.org/10.1016/j.anaerobe.2017.01.001</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kearney S. M., Gibbons S. M., Poyet M., Gurry T., Bullock K., Allegretti J. R., et al. Endospores and other lysis-resistant bacteria comprise a widely shared core community within the human microbiota. The ISME Journal. 2018; 12 (10): 2403–2416. https://doi.org/10.1038/s41396-018-0192-z</mixed-citation><mixed-citation xml:lang="en">Kearney S. M., Gibbons S. M., Poyet M., Gurry T., Bullock K., Allegretti J. R., et al. Endospores and other lysis-resistant bacteria comprise a widely shared core community within the human microbiota. The ISME Journal. 2018; 12 (10): 2403–2416. https://doi.org/10.1038/s41396-018-0192-z</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lan P. T. N., Hayashi H., Sakamoto M., Benno Y. Phylogenetic analysis of cecal microbiota in chicken by the use of 16S rDNA clone libraries. Microbiology and Immunology. 2002; 46 (6): 371–382. https://doi.org/10.1111/j.1348-0421.2002.tb02709.x</mixed-citation><mixed-citation xml:lang="en">Lan P. T. N., Hayashi H., Sakamoto M., Benno Y. Phylogenetic analysis of cecal microbiota in chicken by the use of 16S rDNA clone libraries. Microbiology and Immunology. 2002; 46 (6): 371–382. https://doi.org/10.1111/j.1348-0421.2002.tb02709.x</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Tetz G, Tetz V. Introducing the sporobiota and sporobiome. Gut Pathogens. 2017; 9 (1):38. https://doi:10.1186/s13099-017-0187-8</mixed-citation><mixed-citation xml:lang="en">Tetz G, Tetz V. Introducing the sporobiota and sporobiome. Gut Pathogens. 2017; 9 (1):38. https://doi:10.1186/s13099-017-0187-8</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Elshaghabee F. M., Rokana N., Gulhane R. D., Sharma C., Panwar H. Bacillus as potential probiotics: status, concerns, and future perspectives. Frontiers in Microbiology. 2017; 8:1490. https://doi.org/10.3389/fmicb.2017.01490</mixed-citation><mixed-citation xml:lang="en">Elshaghabee F. M., Rokana N., Gulhane R. D., Sharma C., Panwar H. Bacillus as potential probiotics: status, concerns, and future perspectives. Frontiers in Microbiology. 2017; 8:1490. https://doi.org/10.3389/fmicb.2017.01490</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Egan M., Dempsey E., Ryan C. A., Ross R. P., Stanton C. The sporobiota of the human gut. Gut Microbes. 2021; 13 (1):е1863134. https://doi.org/10.1080/19490976.2020.1863134</mixed-citation><mixed-citation xml:lang="en">Egan M., Dempsey E., Ryan C. A., Ross R. P., Stanton C. The sporobiota of the human gut. Gut Microbes. 2021; 13 (1):е1863134. https://doi.org/10.1080/19490976.2020.1863134</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zeigler D. R., Perkins J. B. The Genus Bacillus. In: Practical Handbook of Microbiology. Ed. by L. H. Green, E. Goldman. 4th ed. Boca Raton: CRC Press; 2021; Chapter 22: 249–278. https://doi.org/10.1201/9781003099277</mixed-citation><mixed-citation xml:lang="en">Zeigler D. R., Perkins J. B. The Genus Bacillus. In: Practical Handbook of Microbiology. Ed. by L. H. Green, E. Goldman. 4th ed. Boca Raton: CRC Press; 2021; Chapter 22: 249–278. https://doi.org/10.1201/9781003099277</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Priest F. G. Systematics and Ecology of Bacillus. In: Bacillus subtilis and Other Gram-Positive Bacteria: Biochemistry, Physiology, and Molecular Genetics. Ed. by A. L. Sonenshein, J. A. Hoch, R. Losick. Washington: American Society for Microbiology; 1993; Chapter 1: 1–16. https://doi.org/10.1128/9781555818388.ch1</mixed-citation><mixed-citation xml:lang="en">Priest F. G. Systematics and Ecology of Bacillus. In: Bacillus subtilis and Other Gram-Positive Bacteria: Biochemistry, Physiology, and Molecular Genetics. Ed. by A. L. Sonenshein, J. A. Hoch, R. Losick. Washington: American Society for Microbiology; 1993; Chapter 1: 1–16. https://doi.org/10.1128/9781555818388.ch1</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Barbosa T. M., Serra C. R., La Ragione R. M., Woodward M. J., Henriques A. O. Screening for Bacillus isolates in the broiler gastrointestinal tract. Applied and Environmental Microbiology. 2005; 71 (2): 968–978. https://doi.org/10.1128/AEM.71.2.968-978.2005</mixed-citation><mixed-citation xml:lang="en">Barbosa T. M., Serra C. R., La Ragione R. M., Woodward M. J., Henriques A. O. Screening for Bacillus isolates in the broiler gastrointestinal tract. Applied and Environmental Microbiology. 2005; 71 (2): 968–978. https://doi.org/10.1128/AEM.71.2.968-978.2005</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hoa T. T., Duc L. H., Isticato R., Baccigalupi L., Ricca E., Van P. H., Cutting S. M. Fate and dissemination of Bacillus subtilis spores in a murine model. Applied and Environmental Microbiology. 2001; 67 (9): 3819–3823. https://doi.org/10.1128/AEM.67.9.3819-3823.2001</mixed-citation><mixed-citation xml:lang="en">Hoa T. T., Duc L. H., Isticato R., Baccigalupi L., Ricca E., Van P. H., Cutting S. M. Fate and dissemination of Bacillus subtilis spores in a murine model. Applied and Environmental Microbiology. 2001; 67 (9): 3819–3823. https://doi.org/10.1128/AEM.67.9.3819-3823.2001</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Mohammed A. A., Zaki R. S., Negm E. A., Mahmoud M. A., Cheng H. W. Effects of dietary supplementation of a probiotic (Bacillus subtilis) on bone mass and meat quality of broiler chickens. Poultry Science. 2021; 100 (3):100906. https://doi.org/10.1016/j.psj.2020.11.073</mixed-citation><mixed-citation xml:lang="en">Mohammed A. A., Zaki R. S., Negm E. A., Mahmoud M. A., Cheng H. W. Effects of dietary supplementation of a probiotic (Bacillus subtilis) on bone mass and meat quality of broiler chickens. Poultry Science. 2021; 100 (3):100906. https://doi.org/10.1016/j.psj.2020.11.073</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Abramowicz K., Krauze M., Ognik K. The effect of a probiotic preparation containing Bacillus subtilis PB6 in the diet of chickens on redox and biochemical parameters in their blood. Annals of Animal Science. 2019; 19 (2): 433–451. https://doi.org/10.2478/aoas-2018-0059</mixed-citation><mixed-citation xml:lang="en">Abramowicz K., Krauze M., Ognik K. The effect of a probiotic preparation containing Bacillus subtilis PB6 in the diet of chickens on redox and biochemical parameters in their blood. Annals of Animal Science. 2019; 19 (2): 433–451. https://doi.org/10.2478/aoas-2018-0059</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Леляк А. А., Штерншис М. В. Антагонистический потенциал сибирских штаммов Bacillus spp. в отношении возбудителей болезней животных и растений. Вестник Томского государственного университета. Биология. 2014; (1): 42–55. https://elibrary.ru/tgwlvz</mixed-citation><mixed-citation xml:lang="en">Lelyak A. A., Shternshis M. V. Antagonistic potential of Siberian strains of Bacillus spp. towards agents causing animal and plant diseases. Tomsk State University Journal of Biology. 2014; (1): 42–55. https://elibrary.ru/tgwlvz (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Dong Y., Li R., Liu Y., Ma L., Zha J., Qiao X., et al. Benefit of dietary supplementation with Bacillus subtilis BYS2 on growth performance, immune response, and disease resistance of broilers. Probiotics and Antimicrobial Proteins. 2020; 12: 1385–1397. https://doi.org/10.1007/s12602-020-09643-w</mixed-citation><mixed-citation xml:lang="en">Dong Y., Li R., Liu Y., Ma L., Zha J., Qiao X., et al. Benefit of dietary supplementation with Bacillus subtilis BYS2 on growth performance, immune response, and disease resistance of broilers. Probiotics and Antimicrobial Proteins. 2020; 12: 1385–1397. https://doi.org/10.1007/s12602-020-09643-w</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов В. В., Резник С. Р., Кудрявцев В. А., Осадчая А. И., Сафронова Л. А. Внеклеточные аминокислоты аэробных спорообразующих бактерий. Микробиология. 1992; 61 (5): 865–872.</mixed-citation><mixed-citation xml:lang="en">SmirnovV. V., Reznik S. R., Kudriavtsev V. A., Osadchaia A. I., Safronova L. A. Extracellular amino acids of aerobic spore-forming bacteria. Mikrobiologiia. 1992; 61 (5): 865–872. https://pubmed.ncbi.nlm.nih.gov/1287408 (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Wu B. Q., Zhang T., Guo L. Q., Lin J. F. Effects of Bacillus subtilis KD1 on broiler intestinal flora. Poultry Science. 2011; 90 (11): 2493–2499. https://doi.org/10.3382/ps.2011-01529</mixed-citation><mixed-citation xml:lang="en">Wu B. Q., Zhang T., Guo L. Q., Lin J. F. Effects of Bacillus subtilis KD1 on broiler intestinal flora. Poultry Science. 2011; 90 (11): 2493–2499. https://doi.org/10.3382/ps.2011-01529</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Sumi C. D., Yang B. W., Yeo I.-C., Hahm Y. T. Antimicrobial peptides of the genus Bacillus: a new era for antibiotics. Canadian Journal of Microbiology. 2015; 61 (2): 93–103. https://doi.org/10.1139/cjm-2014-0613</mixed-citation><mixed-citation xml:lang="en">Sumi C. D., Yang B. W., Yeo I.-C., Hahm Y. T. Antimicrobial peptides of the genus Bacillus: a new era for antibiotics. Canadian Journal of Microbiology. 2015; 61 (2): 93–103. https://doi.org/10.1139/cjm-2014-0613</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Horosheva T. V., Vodyanoy V., Sorokulova I. Efficacy of Bacillus probiotics in prevention of antibiotic‐associated diarrhoea: a randomized, double‐blind, placebo‐controlled clinical trial. JMM Case Reports. 2014; 1 (3):e004036. https://doi.org/10.1099/jmmcr.0.004036</mixed-citation><mixed-citation xml:lang="en">Horosheva T. V., Vodyanoy V., Sorokulova I. Efficacy of Bacillus probiotics in prevention of antibiotic‐associated diarrhoea: a randomized, double‐blind, placebo‐controlled clinical trial. JMM Case Reports. 2014; 1 (3):e004036. https://doi.org/10.1099/jmmcr.0.004036</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Sorokulova I. Modern status and perspectives of Bacillus bacteria as probiotics. Journal of Probiotics &amp; Health. 2013; 1 (4):е106. https://doi.org/10.4172/2329-8901.1000e106</mixed-citation><mixed-citation xml:lang="en">Sorokulova I. Modern status and perspectives of Bacillus bacteria as probiotics. Journal of Probiotics &amp; Health. 2013; 1 (4):е106. https://doi.org/10.4172/2329-8901.1000e106</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Duc L. H., Hong H. A., Uyen N. Q., Cutting S. M. Intracellular fate and immunogenicity of B. subtilis spores. Vaccine. 2004; 22 (15–16): 1873–1885. https://doi.org/10.1016/j.vaccine.2003.11.021</mixed-citation><mixed-citation xml:lang="en">Duc L. H., Hong H. A., Uyen N. Q., Cutting S. M. Intracellular fate and immunogenicity of B. subtilis spores. Vaccine. 2004; 22 (15–16): 1873–1885. https://doi.org/10.1016/j.vaccine.2003.11.021</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Lu S., Na K., Li Y., Zhang L., Fang Y., Guo X. Bacillus-derived probiotics: metabolites and mechanisms involved in bacteria – host interactions. Critical Reviews in Food Science and Nutrition. 2024; 64 (6): 1701–1714. https://doi.org/10.1080/10408398.2022.2118659</mixed-citation><mixed-citation xml:lang="en">Lu S., Na K., Li Y., Zhang L., Fang Y., Guo X. Bacillus-derived probiotics: metabolites and mechanisms involved in bacteria – host interactions. Critical Reviews in Food Science and Nutrition. 2024; 64 (6): 1701–1714. https://doi.org/10.1080/10408398.2022.2118659</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kubota H., Senda S., Nomura N., Tokuda H., Uchiyama H. Biofilm formation by lactic acid bacteria and resistance to environmental stress. Journal of Bioscience and Bioengineering. 2008; 106 (4): 381–386. https://doi.org/10.1263/jbb.106.381</mixed-citation><mixed-citation xml:lang="en">Kubota H., Senda S., Nomura N., Tokuda H., Uchiyama H. Biofilm formation by lactic acid bacteria and resistance to environmental stress. Journal of Bioscience and Bioengineering. 2008; 106 (4): 381–386. https://doi.org/10.1263/jbb.106.381</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Todorov S. D., Ivanova I. V., Popov I., Weeks R., Chikindas M. L. Bacillus spore-forming probiotics: benefits with concerns? Critical Reviews in Microbiology. 2022; 48 (4): 513–530. https://doi.org/10.1080/1040841X.2021.1983517</mixed-citation><mixed-citation xml:lang="en">Todorov S. D., Ivanova I. V., Popov I., Weeks R., Chikindas M. L. Bacillus spore-forming probiotics: benefits with concerns? Critical Reviews in Microbiology. 2022; 48 (4): 513–530. https://doi.org/10.1080/1040841X.2021.1983517</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Costerton J. W., Stewart P. S., Greenberg E. P. Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284 (5418): 1318–1322. https://doi.org/10.1126/science.284.5418.1318</mixed-citation><mixed-citation xml:lang="en">Costerton J. W., Stewart P. S., Greenberg E. P. Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284 (5418): 1318–1322. https://doi.org/10.1126/science.284.5418.1318</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Branda S. S., Vik Å., Friedman L., Kolter R. Biofilms: the matrix revisited. Trends in Microbiology, 2005; 13 (1): 20–26. https://doi.org/10.1016/j.tim.2004.11.006</mixed-citation><mixed-citation xml:lang="en">Branda S. S., Vik Å., Friedman L., Kolter R. Biofilms: the matrix revisited. Trends in Microbiology, 2005; 13 (1): 20–26. https://doi.org/10.1016/j.tim.2004.11.006</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Lasa I., Penadés J. R. Bap: a family of surface proteins involved in biofilm formation. Research in Microbiology. 2006; 157 (2): 99–107. https://doi.org/10.1016/j.resmic.2005.11.003</mixed-citation><mixed-citation xml:lang="en">Lasa I., Penadés J. R. Bap: a family of surface proteins involved in biofilm formation. Research in Microbiology. 2006; 157 (2): 99–107. https://doi.org/10.1016/j.resmic.2005.11.003</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Taglialegna A., Lasa I., Valle J. Amyloid structures as biofilm matrix scaffolds. Journal of Bacteriology. 2016; 198 (19): 2579–2588. https://doi.org/10.1128/jb.00122-16</mixed-citation><mixed-citation xml:lang="en">Taglialegna A., Lasa I., Valle J. Amyloid structures as biofilm matrix scaffolds. Journal of Bacteriology. 2016; 198 (19): 2579–2588. https://doi.org/10.1128/jb.00122-16</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Akbey Ü., Andreasen M. Functional amyloids from bacterial biofilms – structural properties and interaction partners. Chemical Science. 2022; 13 (22): 6457–6477. https://doi.org/10.1039/D2SC00645F</mixed-citation><mixed-citation xml:lang="en">Akbey Ü., Andreasen M. Functional amyloids from bacterial biofilms – structural properties and interaction partners. Chemical Science. 2022; 13 (22): 6457–6477. https://doi.org/10.1039/D2SC00645F</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Cámara-Almirón J. Structural and functional study of bacterial amyloids in Bacillus subtilis: Author’s thesis. Universidad de Málaga; 2020. https://hdl.handle.net/10630/19863</mixed-citation><mixed-citation xml:lang="en">Cámara-Almirón J. Structural and functional study of bacterial amyloids in Bacillus subtilis: Author’s thesis. Universidad de Málaga; 2020. https://hdl.handle.net/10630/19863</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Fazeli-Nasab B., Sayyed R. Z., Mojahed L. S., Rahmani A. F., Ghafari M., Antonius S., Sukamto. Biofilm production: a strategic mechanism for survival of microbes under stress conditions. Biocatalysis and Agricultural Biotechnology. 2022; 42:102337. https://doi.org/10.1016/j.bcab.2022.102337</mixed-citation><mixed-citation xml:lang="en">Fazeli-Nasab B., Sayyed R. Z., Mojahed L. S., Rahmani A. F., Ghafari M., Antonius S., Sukamto. Biofilm production: a strategic mechanism for survival of microbes under stress conditions. Biocatalysis and Agricultural Biotechnology. 2022; 42:102337. https://doi.org/10.1016/j.bcab.2022.102337</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Freeman D. J., Falkiner F. R., Keane C. T. New method for detecting slime production by coagulase negative staphylococci. Journal of Clinical Pathology. 1989; 42 (8): 872–874. https://doi.org/10.1136/jcp.42.8.872</mixed-citation><mixed-citation xml:lang="en">Freeman D. J., Falkiner F. R., Keane C. T. New method for detecting slime production by coagulase negative staphylococci. Journal of Clinical Pathology. 1989; 42 (8): 872–874. https://doi.org/10.1136/jcp.42.8.872</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Saxena N., Maheshwari D., Dadhich D., Singh S. Evaluation of Congo red agar for detection of biofilm production by various clinical Candida isolates. Journal of Evolution of Medical and Dental Sciences. 2014; 3 (59): 13234–13238. https://doi.org/10.14260/jemds/2014/3761</mixed-citation><mixed-citation xml:lang="en">Saxena N., Maheshwari D., Dadhich D., Singh S. Evaluation of Congo red agar for detection of biofilm production by various clinical Candida isolates. Journal of Evolution of Medical and Dental Sciences. 2014; 3 (59): 13234–13238. https://doi.org/10.14260/jemds/2014/3761</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Branda S. S., Chu F., Kearns D. B., Losick R., Kolter R. A major protein component of the Bacillus subtilis biofilm matrix. Molecular Microbiology. 2006; 59 (4): 1229–1238. https://doi.org/10.1111/j.1365-2958.2005.05020.x</mixed-citation><mixed-citation xml:lang="en">Branda S. S., Chu F., Kearns D. B., Losick R., Kolter R. A major protein component of the Bacillus subtilis biofilm matrix. Molecular Microbiology. 2006; 59 (4): 1229–1238. https://doi.org/10.1111/j.1365-2958.2005.05020.x</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Romero D., Aguilar C., Losick R., Kolter R. Amyloid fibers provide structural integrity to Bacillus subtilis biofilms. Proceedings of the National Academy of Sciences. 2010; 107 (5): 2230–2234. https://doi.org/10.1073/pnas.0910560107</mixed-citation><mixed-citation xml:lang="en">Romero D., Aguilar C., Losick R., Kolter R. Amyloid fibers provide structural integrity to Bacillus subtilis biofilms. Proceedings of the National Academy of Sciences. 2010; 107 (5): 2230–2234. https://doi.org/10.1073/pnas.0910560107</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Lindsay D., Brözel V. S., Von Holy A. Spore formation in Bacillus subtilis biofilms. Journal of Food Protection. 2005; 68 (4): 860–865. https://doi.org/10.4315/0362-028X-68.4.860</mixed-citation><mixed-citation xml:lang="en">Lindsay D., Brözel V. S., Von Holy A. Spore formation in Bacillus subtilis biofilms. Journal of Food Protection. 2005; 68 (4): 860–865. https://doi.org/10.4315/0362-028X-68.4.860</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Bengtsson-Palme J., Abramova A., Berendonk T. U., Coelho L. P., Forslund S. K., Gschwind R., et al. Towards monitoring of antimicrobial resistance in the environment: For what reasons, how to implement it, and what are the data needs? Environment International. 2023; 178: 108089. https://doi.org/10.1016/j.envint.2023.108089</mixed-citation><mixed-citation xml:lang="en">Bengtsson-Palme J., Abramova A., Berendonk T. U., Coelho L. P., Forslund S. K., Gschwind R., et al. Towards monitoring of antimicrobial resistance in the environment: For what reasons, how to implement it, and what are the data needs? Environment International. 2023; 178: 108089. https://doi.org/10.1016/j.envint.2023.108089</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Dulya O., Mikryukov V., Shchepkin D. V., Pent M., Tamm H., Guazzini M., et al. A trait-based ecological perspective on the soil microbial antibiotic-related genetic machinery. Environment International. 2024; 190:108917. https://doi.org/10.1016/j.envint.2024.108917</mixed-citation><mixed-citation xml:lang="en">Dulya O., Mikryukov V., Shchepkin D. V., Pent M., Tamm H., Guazzini M., et al. A trait-based ecological perspective on the soil microbial antibiotic-related genetic machinery. Environment International. 2024; 190:108917. https://doi.org/10.1016/j.envint.2024.108917</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">BerićT., Biočanin M., Stanković S., Dimkić I., Janakiev T., Fira Đ., Lozo J. Identification and antibiotic resistance of Bacillus spp. isolates from natural samples. Archives of Biological Sciences. 2018; 70 (3): 581–588. https://doi.org/10.2298/ABS180302019B</mixed-citation><mixed-citation xml:lang="en">BerićT., Biočanin M., Stanković S., Dimkić I., Janakiev T., Fira Đ., Lozo J. Identification and antibiotic resistance of Bacillus spp. isolates from natural samples. Archives of Biological Sciences. 2018; 70 (3): 581–588. https://doi.org/10.2298/ABS180302019B</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Adamski P., Byczkowska-Rostkowska Z., Gajewska J., Zakrzewski A. J., Kłębukowska L. Prevalence and antibiotic resistance of Bacillus sp. isolated from raw milk. Microorganisms. 2023; 11 (4):1065. https://doi.org/10.3390/microorganisms11041065</mixed-citation><mixed-citation xml:lang="en">Adamski P., Byczkowska-Rostkowska Z., Gajewska J., Zakrzewski A. J., Kłębukowska L. Prevalence and antibiotic resistance of Bacillus sp. isolated from raw milk. Microorganisms. 2023; 11 (4):1065. https://doi.org/10.3390/microorganisms11041065</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Kowalska J., Maćkiw E., Stasiak M., Kucharek K., Postupolski J. Biofilm-forming ability of pathogenic bacteria isolated from retail food in Poland. Journal of Food Protection. 2020; 83 (12): 2032–2040. https://doi.org/10.4315/JFP-20-135</mixed-citation><mixed-citation xml:lang="en">Kowalska J., Maćkiw E., Stasiak M., Kucharek K., Postupolski J. Biofilm-forming ability of pathogenic bacteria isolated from retail food in Poland. Journal of Food Protection. 2020; 83 (12): 2032–2040. https://doi.org/10.4315/JFP-20-135</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Morikawa M. Beneficial biofilm formation by industrial bacteria Bacillus subtilis and related species. Journal of Bioscience and Bioengineering. 2006; 101 (1): 1–8. https://doi.org/10.1263/jbb.101.1</mixed-citation><mixed-citation xml:lang="en">Morikawa M. Beneficial biofilm formation by industrial bacteria Bacillus subtilis and related species. Journal of Bioscience and Bioengineering. 2006; 101 (1): 1–8. https://doi.org/10.1263/jbb.101.1</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Bernheimer A. W., Avigad L. S. Nature and properties of a cytolytic agent produced by Bacillus subtilis. Microbiology. 1970; 61 (3): 361–369. https://doi.org/10.1099/00221287-61-3-361</mixed-citation><mixed-citation xml:lang="en">Bernheimer A. W., Avigad L. S. Nature and properties of a cytolytic agent produced by Bacillus subtilis. Microbiology. 1970; 61 (3): 361–369. https://doi.org/10.1099/00221287-61-3-361</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">AlGburi A., Volski A., Cugini C., Walsh E. М., Chistyakov V. А., Mazanko M. S., et al. Safety properties and probiotic potential of Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895. Advances in Microbiology. 2016; 6 (6): 432–452. https://doi.org/10.4236/aim.2016.66043</mixed-citation><mixed-citation xml:lang="en">AlGburi A., Volski A., Cugini C., Walsh E. М., Chistyakov V. А., Mazanko M. S., et al. Safety properties and probiotic potential of Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895. Advances in Microbiology. 2016; 6 (6): 432–452. https://doi.org/10.4236/aim.2016.66043</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Deng F., Chen Y., Sun T., Wu Y., Su Y., Liu C., et al. Antimicrobial resistance, virulence characteristics and genotypes of Bacillus spp. from probiotic products of diverse origins. Food Research International. 2021; 139:109949. https://doi.org/10.1016/j.foodres.2020.109949</mixed-citation><mixed-citation xml:lang="en">Deng F., Chen Y., Sun T., Wu Y., Su Y., Liu C., et al. Antimicrobial resistance, virulence characteristics and genotypes of Bacillus spp. from probiotic products of diverse origins. Food Research International. 2021; 139:109949. https://doi.org/10.1016/j.foodres.2020.109949</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Похиленко В. Д., Перелыгин В. В. Пробиотики на основе спорообразующих бактерий и их безопасность. Химическая и биологическая безопасность. 2007; (2–3): 20–41. http://www.cbsafety.ru/rus/saf_32_2.asp</mixed-citation><mixed-citation xml:lang="en">Pokhilenko V. D., Perelygin V. V. Probiotics on the basis of spore-forming bacteria and their safety. Chemical and Biological Safety. 2007; (2–3): 20–41. https://www.cbsafety.ru/rus/saf_32_2.asp (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Otiniano N. M., Farfán-Córdova M., Cabeza J. G., Cabanillas-Chirinos L. Isolation and selection of spore-forming bacilli with potential for self-healing of concrete. Scientific Reports. 2024; 14:27223. https://doi.org/10.1038/s41598-024-77241-9</mixed-citation><mixed-citation xml:lang="en">Otiniano N. M., Farfán-Córdova M., Cabeza J. G., Cabanillas-Chirinos L. Isolation and selection of spore-forming bacilli with potential for self-healing of concrete. Scientific Reports. 2024; 14:27223. https://doi.org/10.1038/s41598-024-77241-9</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Buxton R. Blood agar plates and hemolysis protocols. American Society for Microbiology. 30 September 2005. 9 p. https://asm.org/getattachment/7ec0de2b-bb16-4f6e-ba07-2aea25a43e76/protocol</mixed-citation><mixed-citation xml:lang="en">Buxton R. Blood agar plates and hemolysis protocols. American Society for Microbiology. 30 September 2005. 9 p. https://asm.org/getattachment/7ec0de2b-bb16-4f6e-ba07-2aea25a43e76/protocol</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">ОФС.1.7.2.0012.15. Производственные пробиотические штаммы и штаммы для контроля пробиотиков. Государственная фармакопея Российской Федерации. XIV издание. https://pharmacopoeia.regmed.ru/pharmacopoeia/izdanie-14/1/1-7/1-7-2/proizvodstvennye-probioticheskie-shtammy-i-shtammy-dlya-kontrolya-probiotikov</mixed-citation><mixed-citation xml:lang="en">General Pharmacopoeia Monograph GPM.1.7.2.0012.15. Production probiotic strains and strains for probiotic control. The State Pharmacopoeia of the Russian Federation. XIV ed. https://pharmacopoeia.regmed.ru/pharmacopoeia/izdanie-14/1/1-7/1-7-2/proizvodstvennye-probioticheskie-shtammy-i-shtammy-dlya-kontrolya-probiotikov (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Определение чувствительности микроорганизмов к антимикробным препаратам: рекомендации Межрегиональной ассоциации по клинической микробиологии и антимикробной химиотерапии. Версия 2021-01. https://www.antibiotic.ru/files/321/clrec-dsma2021.pdf</mixed-citation><mixed-citation xml:lang="en">Determination of the sensitivity of microorganisms to antimicrobial agents: recommendations of the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy. Version 2021-01. https://www.antibiotic.ru/files/321/clrec-dsma2021.pdf (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA Journal. 2012; 10 (6):2740. https://doi.org/10.2903/j.efsa.2012.2740</mixed-citation><mixed-citation xml:lang="en">EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA Journal. 2012; 10 (6):2740. https://doi.org/10.2903/j.efsa.2012.2740</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Okouakoua F. Y., Kayath C. A., Mokemiabeka S. N., Moukala D. C. R., Kaya-Ongoto M. D., Nguimbi E. Involvement of the Bacillus SecYEG pathway in biosurfactant production and biofilm formation. International Journal of Microbiology. 2024; 2024:6627190. https://doi.org/10.1155/2024/6627190</mixed-citation><mixed-citation xml:lang="en">Okouakoua F. Y., Kayath C. A., Mokemiabeka S. N., Moukala D. C. R., Kaya-Ongoto M. D., Nguimbi E. Involvement of the Bacillus SecYEG pathway in biosurfactant production and biofilm formation. International Journal of Microbiology. 2024; 2024:6627190. https://doi.org/10.1155/2024/6627190</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
